MoneyWorks4Me

Chandra Bhagat Pharma submits board meeting intimation

30 Jul 2026 Evaluate
Chandra Bhagat Pharma has informed that pursuant to Regulation 29(1)(d) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, a meeting of the Board of Directors (Board Meeting) of Chandra Bhagat Pharma (the Company) is scheduled to be held on Wednesday 5th August, 2026, to increasing in Authorised Share Capital of Company; to consider a proposal of fund raising by issue of Equity Shares/ convertible warrants and/or any other instruments through Preferential allotment towards consideration for cash or other than cash, subject to approval of shareholders and compliances of applicable provision of law; to fix the date, time, place for holding the Extra Ordinary General Meeting (EOGM) for obtaining shareholders’ approval for aforesaid preferential issue and other agenda items; and any other business with the permission of the chair which is incidental and ancillary to the business. Pursuant to the Code of Conduct for prevention of insider trading (the Code of Conduct), framed in accordance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time, the trading window for dealing in the securities shall remain closed for all connected persons / officers / designated employees / insiders, directors of the Company and immediate relatives of these persons, including but not limited to the persons specified in the Company's Code of Conduct from 30th July, 2026 till the end of 48 hours from the conclusion of the Board Meeting.

The above information is a part of company’s filings submitted to BSE.

Chandra Bhagat Pharm Share Price

43.38 2.06 (4.99%)
07-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1949.00
Dr. Reddys Labs. 1172.00
Cipla 1472.00
Lupin 2360.00
Zydus Lifesciences 1115.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: